School of Chemical and Biotechnology (SCBT), SASTRA Deemed University, Thanjavur, India.
J Biochem Mol Toxicol. 2020 Apr;34(4):e22457. doi: 10.1002/jbt.22457. Epub 2020 Feb 5.
Diabetic heart (diabetes mellitus [DM]) has been shown to attenuate the beneficial effect of ischemic preconditioning (IPC) in rat heart. But the effect of IPC on diabetic rat heart that develops myopathy remains unclear. This study was designed to test the impact of IPC on diabetic cardiomyopathy (DCM) rat heart. Male Wistar rats were grouped as (a) normal, (b) DM (streptozotocin: 65 mg/kg; fed with normal diet), and (c) DCM (streptozotocin: 65 mg/kg; fed with high-fat diet). Isolated rat hearts from each group were randomly subjected to (a) normal perfusion, (b) ischemia-reperfusion (I/R), and (c) IPC procedure. At the end of the perfusion experiments, hearts were analyzed for injury, contractile function, mitochondrial activity, and oxidative stress. The results obtained from hemodynamics, cardiac injury markers, and caspase-3 activity showed that DCM rat displayed prominent I/R-associated cardiac abnormalities than DM rat heart. But the deteriorated physiological performance and cardiac injury were not recovered in both DM and DCM heart by IPC procedure. Unlike normal rat heart, IPC did not reverse mitochondrial dysfunction (determined by electron transport chain enzymes activity, ATP level, and membrane integrity, expression levels of genes like PGC-1ɑ, GSK3β, complex I, II, and V) in DCM and DM rat heart. The present study demonstrated that IPC failed to protect I/R-challenged DCM rat heart, and the underlying pathology was associated with deteriorated mitochondrial function.
糖尿病心脏(糖尿病[DM])已被证明可减弱缺血预处理(IPC)对大鼠心脏的有益作用。但是,IPC 对发生肌病的糖尿病大鼠心脏的影响尚不清楚。本研究旨在测试 IPC 对糖尿病心肌病(DCM)大鼠心脏的影响。雄性 Wistar 大鼠分为以下三组:(a)正常组;(b)DM 组(链脲佐菌素:65mg/kg;正常饮食喂养);(c)DCM 组(链脲佐菌素:65mg/kg;高脂饮食喂养)。每组大鼠的离体心脏随机接受以下处理:(a)正常灌注;(b)缺血再灌注(I/R);(c)IPC 处理。在灌注实验结束时,分析心脏损伤、收缩功能、线粒体活性和氧化应激。从血流动力学、心脏损伤标志物和 caspase-3 活性得出的结果表明,与 DM 大鼠心脏相比,DCM 大鼠的 I/R 相关心脏异常更为明显。但是,IPC 程序并没有恢复 DM 和 DCM 心脏的生理功能障碍和心脏损伤。与正常大鼠心脏不同,IPC 并没有逆转 DCM 和 DM 大鼠心脏中的线粒体功能障碍(通过电子传递链酶活性、ATP 水平和膜完整性、PGC-1α、GSK3β、复合物 I、II 和 V 的基因表达水平来确定)。本研究表明,IPC 未能保护 I/R 挑战的 DCM 大鼠心脏,潜在的病理与恶化的线粒体功能有关。